Reduction of aversive learning rates in Pavlovian conditioning by angiotensin 
II antagonist losartan: A randomized controlled trial

Zika, Ondrej; Appel, Judith; Klinge, Corinna; Shkreli, Lorika; Browning, Michael; Wiech, Katja; Reinecke, Andrea

doi:10.1016/j.biopsych.2024.01.020

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Reduction of aversive learning rates in Pavlovian conditioning by angiotensin II antagonist losartan: A randomized controlled trial

MPS-Authors

/persons/resource/persons255868

Zika, Ondrej
Max Planck Research Group NeuroCode - Neural and Computational Basis of Learning, Memory and Decision Making, Max Planck Institute for Human Development, Max Planck Society;
Max Planck UCL Centre for Computational Psychiatry and Ageing Research, Berlin, Germany, and London, UK, Max Planck Institute for Human Development, Max Planck Society;

External Resource

https://doi.org/10.31234/osf.io/e5wdv
(Preprint)

https://doi.org/10.1016/j.biopsych.2024.01.020
(Publisher version)

https://github.com/ozika/aversive-learning-losartan-zika2023
(Research data)

https://github.com/ozika/aversive-learning-losartan-zika2023
(Code)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Zika, O., Appel, J., Klinge, C., Shkreli, L., Browning, M., Wiech, K., et al. (2024). Reduction of aversive learning rates in Pavlovian conditioning by angiotensin II antagonist losartan: A randomized controlled trial. Biological Psychiatry. doi:10.1016/j.biopsych.2024.01.020.

Cite as: https://hdl.handle.net/21.11116/0000-000D-315D-4

Abstract

There is no abstract available